Overview

Treatment for Cognitive Impairment in Depression

Status:
Withdrawn
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The proposed study seeks to investigate the effects of modafinil on cognitive function in depression, which holds promise for better treating cognitive impairment in depression, as well as better understand cognitive dysfunction in MDD from a neural rather than diagnostic point of view to better classify and treat these disabling symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Stanford University
Treatments:
Modafinil